Concepedia

Amy Westerling-Bui

AW

Statistics

Publications

2

Citations

89

H-Index

2

Active since

2019

Affiliations

Goldfinch Bio (United States)(Current)

Amy Westerling-Bui is an author at Goldfinch Bio (United States) specializing in pharmacodynamics in kidney disease, renal drug distribution, and protamine sulfate.

ORCID

Publications per year

2019–2022

2

Publications

2

Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model

Maolin Yu, Mark W. Ledeboer, Matthew H. Daniels et al. · ACS Medicinal Chemistry Letters · 2019 · 60 citations · Full text

, , +17

Transplanted organoids empower human preclinical assessment of drug candidate for the clinic

Amy Westerling-Bui, Eva M. Fast, Thomas W. Soare et al. · Science Advances · 2022 · 29 citations · Full text

, , +17

1–2 of 2